Your cart:£0.00(0 items) Check yourbonu$
Site search:
Categories list

Generic Emflaza (Deflazacort)

Emflaza is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients at the age of 5 and older.

PackagePricePer pillSavingsOrder
6mg × 10 tablet£21.47£2.15Add to cart
6mg × 20 tablet£35.80£1.79£7.13Add to cart
6mg × 30 tablet£42.97£1.43£21.43Add to cart
6mg × 60 tablet£53.72£0.90£75.07Add to cart
6mg × 90 tablet£64.47£0.72£128.72Add to cart
6mg × 120 tablet£71.63£0.60£185.95Add to cart

PackagePricePer pillSavingsOrder
24mg × 12 tablet£50.13£4.18Add to cart
24mg × 24 tablet£93.14£3.88£7.13Add to cart
24mg × 36 tablet£136.14£3.78£14.26Add to cart
24mg × 60 tablet£214.97£3.58£35.69Add to cart
24mg × 90 tablet£311.73£3.46£64.27Add to cart

PackagePricePer pillSavingsOrder
30mg × 12 tablet£64.47£5.37Add to cart
30mg × 24 tablet£114.64£4.78£14.30Add to cart
30mg × 36 tablet£164.81£4.58£28.60Add to cart
30mg × 60 tablet£257.98£4.30£64.36Add to cart
Most popular quantity.

Products from the same category

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.

Choose Your language:
Social bookmarks:
Testimonials
Just to inform you that your package was received Friday 27 th October 14 days after dispatch , excellent service , no problems with customs , also thank you for free extra tablets , you can if you wish use this letter as a recommendation for your company , many thanks
Read more »

Our billing is certified by:

Secure shopping certificates


Special Offer!

PTC Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update - PRNewswire
PTC Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update  PRNewswire
PTC aims again for FDA review of Duchenne drug despite latest miss - BioPharma Dive
PTC aims again for FDA review of Duchenne drug despite latest miss  BioPharma Dive
Amber Specialty Pharmacy Selected by PTC Therapeutics, Inc. to Dispense EMFLAZA® for Duchenne Muscular Dystrophy Patients - Business Wire
Amber Specialty Pharmacy Selected by PTC Therapeutics, Inc
Orsini Specialty Pharmacy Selected By PTC Therapeutics As A Limited Distribution Partner For EMFLAZA® (deflazacort) - PRNewswire
Orsini Specialty Pharmacy Selected By PTC Therapeutics As A Limited Distribution Partner For EMFLAZA® (deflazacort)  PRNewswire
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, Analysis, Growth ratio, Top Players and Fut - PharmiWeb.com
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, Analysis, Growth ratio, Top Players and Fut  PharmiWeb
Centralux Ltd
bookmark Bookmark this site
Subscribe to the News